Ratings by Nephron (Jack Meehan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/12/2026 | ICON plc | ICLR | Downgrade | Hold (Buy) |
133.14 (107.20) |
-19.48% | Details | |
| 11/21/2025 | Exact Sciences | EXAS | Downgrade | Hold (Buy) |
100.67 (103.50) |
2.81% | Details | |
| 11/4/2025 | Bruker | BRKR | Upgrade | Hold (Sell) |
38.94 (36.68) |
-5.8% | Details | |
| 10/30/2025 | Guardant Health | GH | Upgrade | Hold (Sell) |
69.58 (91.20) |
31.07% | Details | |
| 7/9/2025 | Quidel Corp. | QDEL | Downgrade | Hold (Buy) |
30.82 (20.83) |
-32.41% | Details | |
| 3/27/2025 | Quest Diagnostics | DGX | Downgrade | Hold (Buy) |
166.62 (199.21) |
19.56% | Details | |
| 3/6/2025 | Waters Corp. | WAT | Upgrade | Buy (Hold) |
378.89 (302.54) |
-20.15% | Details | |
| 12/11/2024 | Hologic | HOLX | Downgrade | Hold (Buy) |
76.83 (75.74) |
-1.42% | Details | |
| 12/2/2024 | ICON plc | ICLR | Upgrade | Buy (Hold) |
210.25 (133.14) |
-36.68% | Details | |
| 12/2/2024 | IQVIA Holdings | IQV | Upgrade | Buy (Hold) |
200.84 (174.49) |
-13.12% | Details | |
| 11/11/2024 | Revvity Inc | RVTY | Downgrade | Sell (Hold) |
122.47 (91.34) |
-25.42% | Details | |
| 10/7/2024 | Revvity Inc | RVTY | Downgrade | Hold (Buy) |
123.96 (91.34) |
-26.31% | Details | |
| 8/28/2024 | Bio-Rad Labs | BIO | Upgrade | Buy (Hold) |
319.37 (269.85) |
-15.51% | Details | |
| 8/26/2024 | Guardant Health | GH | Downgrade | Sell (Hold) |
29.02 (69.58) |
139.77% | Details | |
| 6/5/2024 | Illumina | ILMN | Upgrade | Hold (Sell) |
102.06 (124.62) |
22.1% | Details | |
| 5/29/2024 | Bruker | BRKR | Downgrade | Sell (Hold) |
75.86 (38.94) |
-48.67% | Details | |
| 4/16/2024 | Pacific Biosciences of California | PACB | Downgrade | Hold (Buy) |
2.83 (1.38) |
-51.24% | Details | |
| 2/20/2024 | Quidel Corp. | QDEL | Upgrade | Buy (Hold) |
41.76 (30.82) |
-26.2% | Details | |
| 2/5/2024 | Catalent | CTLT | Downgrade | Hold (Buy) |
54.51 (63.48) |
16.46% | Details | |
| 1/31/2024 | Danaher | DHR | Upgrade | Buy (Hold) |
233.93 (195.50) |
-16.43% | Details | |
| 1/29/2024 | Thermo Fisher Scientific | TMO | Upgrade | Buy (Hold) |
547.33 (501.97) |
-8.29% | Details | |
| 10/5/2023 | Thermo Fisher Scientific | TMO | Downgrade | Hold (Buy) |
502.45 (501.97) |
-0.1% | Details | |
| 7/11/2023 | IQVIA Holdings | IQV | Downgrade | Hold (Buy) |
216.81 (174.49) |
-19.52% | Details | |
| 5/16/2023 | Pacific Biosciences of California | PACB | New Coverage | Buy (N/A) |
12.44 (1.38) |
-88.91% | Details | |
| 4/14/2023 | Catalent | CTLT | Upgrade | Buy (Sell) |
63.31 (63.48) |
0.27% | Details |
